Table 1.
Clinical trials on resveratrol and cancer recorded on US and EU registers.
| Title (identifier number) | Condition(s) |
|---|---|
| www.clinicaltrials.gov | |
| Resveratrol for Patients with Colon Cancer (NCT00256334) | Colon cancer |
| Resveratrol in Treating Patients with Colorectal Cancer that Can Be Removed by Surgery (NCT00433576) | Adenocarcinoma of the colon/rectum |
| A Biological Study of Resveratrol’s Effects on Notch-1 Signaling in Subjects with Low-Grade Gastrointestinal Tumors (NCT01476592) | Neuroendocrine tumor |
| Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention (NCT00578396) | Colon cancer |
| Resveratrol and Human Hepatocyte Function in Cancer (NCT02261844) | Liver cancer |
| A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects with Colorectal Cancer and Hepatic Metastases (NCT00920803) | Colon-rectal cancer |
| UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants (NCT00098969) | Unspecified adult solid tumors |
| A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma (NCT00920556) | Multiple myeloma |
| www.clinicaltrialsregister.eu | |
| Prostate Phytochemical & PUFA Intervention (EudraCT Number: 2006-006679-18) | Localized prostate cancer |